ACLX
Price
$63.34
Change
-$1.87 (-2.87%)
Updated
May 23, 01:46 PM (EDT)
Capitalization
3.59B
87 days until earnings call
MLYS
Price
$16.59
Change
-$0.07 (-0.42%)
Updated
May 23, 02:07 PM (EDT)
Capitalization
1.06B
80 days until earnings call
Interact to see
Advertisement

ACLX vs MLYS

Header iconACLX vs MLYS Comparison
Open Charts ACLX vs MLYSBanner chart's image
Arcellx
Price$63.34
Change-$1.87 (-2.87%)
Volume$500
Capitalization3.59B
Mineralys Therapeutics
Price$16.59
Change-$0.07 (-0.42%)
Volume$100
Capitalization1.06B
ACLX vs MLYS Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. MLYS commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and MLYS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (ACLX: $65.21 vs. MLYS: $16.66)
Brand notoriety: ACLX and MLYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 196% vs. MLYS: 1%
Market capitalization -- ACLX: $3.59B vs. MLYS: $1.06B
ACLX [@Biotechnology] is valued at $3.59B. MLYS’s [@Biotechnology] market capitalization is $1.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileMLYS’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • MLYS’s FA Score: 0 green, 5 red.
According to our system of comparison, MLYS is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 6 TA indicator(s) are bullish while MLYS’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 6 bullish, 3 bearish.
  • MLYS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than MLYS.

Price Growth

ACLX (@Biotechnology) experienced а +11.57% price change this week, while MLYS (@Biotechnology) price change was +8.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.71%. For the same industry, the average monthly price growth was +2.75%, and the average quarterly price growth was -2.89%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

MLYS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+0.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.59B) has a higher market cap than MLYS($1.06B). MLYS YTD gains are higher at: 35.337 vs. ACLX (-14.969). ACLX has higher annual earnings (EBITDA): -153.96M vs. MLYS (-192.36M). ACLX has more cash in the bank: 543M vs. MLYS (198M). ACLX has higher revenues than MLYS: ACLX (76.8M) vs MLYS (0).
ACLXMLYSACLX / MLYS
Capitalization3.59B1.06B338%
EBITDA-153.96M-192.36M80%
Gain YTD-14.96935.337-42%
P/E RatioN/AN/A-
Revenue76.8M0-
Total Cash543M198M274%
Total Debt53.2MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ACLXMLYS
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 18 days ago
79%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAMHX34.700.03
+0.09%
American Funds American Balanced R2E
OTPSX34.08N/A
N/A
ProFunds NASDAQ-100 Svc
GDSRX23.09N/A
N/A
Goldman Sachs Small Cap Eq Insghts R
BAUAX25.71N/A
N/A
Brown Advisory Small-Cap Fdmtl Val Adv
FUMIX17.94N/A
N/A
Fidelity SAI US Momentum Index

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with KRYS. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-0.50%
KRYS - ACLX
59%
Loosely correlated
N/A
CGON - ACLX
57%
Loosely correlated
-1.75%
RCKT - ACLX
57%
Loosely correlated
N/A
RNA - ACLX
55%
Loosely correlated
N/A
XNCR - ACLX
54%
Loosely correlated
+2.26%
More

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with PTGX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
N/A
PTGX - MLYS
49%
Loosely correlated
N/A
CKPT - MLYS
41%
Loosely correlated
N/A
XERS - MLYS
38%
Loosely correlated
N/A
ACLX - MLYS
35%
Loosely correlated
-0.50%
APGE - MLYS
35%
Loosely correlated
+0.45%
More